Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free SDCCQ Stock Alerts

SmileDirectClub (SDCCQ) Competitors

Compare

SDCCQ vs. TTOO, GMVDF, VRAYQ, AFIB, and UTRS

Should you buy SmileDirectClub stock or one of its competitors? MarketBeat compares SmileDirectClub with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SmileDirectClub include T2 Biosystems (TTOO), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does SmileDirectClub compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, T2 Biosystems had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for SmileDirectClub. T2 Biosystems' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
SmileDirectClub Neutral

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
SmileDirectClub N/A N/A N/A

T2 Biosystems has higher earnings, but lower revenue than SmileDirectClub. T2 Biosystems is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

T2 Biosystems has a beta of 7.8, suggesting that its share price is 680% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

T2 Biosystems and SmileDirectClub tied by winning 5 of the 10 factors compared between the two stocks.

How does SmileDirectClub compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

G Medical Innovations has a beta of 27.28, suggesting that its share price is 2,628% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33M-$0.31N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

ViewRay has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
ViewRay Neutral
SmileDirectClub Neutral

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
SmileDirectClub N/A N/A N/A

Summary

SmileDirectClub beats ViewRay on 5 of the 7 factors compared between the two stocks.

How does SmileDirectClub compare to Acutus Medical?

SmileDirectClub (NASDAQ:SDCCQ) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

SmileDirectClub has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.68, meaning that its stock price is 468% more volatile than the broader market.

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Acutus Medical has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Acutus Medical Neutral

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Summary

SmileDirectClub beats Acutus Medical on 6 of the 10 factors compared between the two stocks.

How does SmileDirectClub compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
SmileDirectClub Neutral

Minerva Surgical has a beta of 2.92, indicating that its stock price is 192% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
SmileDirectClub N/A N/A N/A

Minerva Surgical has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

0.1% of SmileDirectClub shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

SmileDirectClub beats Minerva Surgical on 4 of the 7 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

Export
MetricSmileDirectClubDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$40K$2.87M$6.52B$12.05B
Dividend YieldN/AN/A2.67%5.66%
P/E Ratio0.00N/A24.0024.42
Price / SalesN/A0.06515.84118.72
Price / CashN/AN/A27.4837.92
Price / BookN/A0.0110.606.82
Net Income-$86.40M-$60.92M$3.57B$337.56M

SmileDirectClub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-99.7%$42K$7.68MN/A180
GMVDF
G Medical Innovations
N/A$0.00
flat		N/AN/A$26K$4.42MN/A72
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$6K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel